OSIVAX
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • CAREERS >
      • Analyste Business Development
      • Technicien R&D (H/F) Poste en CDD de 6 mois, basé à Lyon (69)
    • LEGAL MENTIONS
SCIENTIFIC ADVISORY BOARD
Picture


​

Dr. Tim MOSMANN, 
Member of the Scientific Advisory Board

Dr. Tim Mosmann is Director of the human immunology center at the University of Rochester, with more than forty years of experience and major contributions in T cell mediated immunity

Expertise:
  • Established a high-throughput proliferation and cytotoxicity assay for cytokines
  • Used this assay to show that there were discrete patterns of cytokines produced by different T cell lines. This work expanded into the characterization of different functions and further cytokine patterns of Th1 and Th2 T cells
  • Demonstrated that effector T cells were specialized for different functions, and laid the groundwork for more recent demonstrations of additional stable or semi-stable T cell subsets
  • Led to the prediction of a cross-regulatory cytokine, resulting in the discovery of IL-10
  • Worked on a subset of uncommitted precursor T memory cells that constitute a surprisingly large proportion of many human immune responses
  • Is working on the objective analysis of flow cytometry data, collaborating on the development of algorithms that allow objective mining of the rich information contained in flow cytometry datasets

Prior Experience:
  • Director of the Human Immunology Center, University of Rochester, USA (1998-present)
  • Professor and Chair, Department of Immunology, University of Alberta, Canada (1990-1998)
  • Research Scientist, DNAX then acquired by Schering plough, Palo Alto, USA (1982-1990)
  • Assistant Professor, University of Alberta (1977-1982)
  • Post-doctoral fellow, University of Glasgow (1975-1977)
  • Post-doctoral fellow, Hospital for Sick Children, University of Toronto (1973-1975)

Award:
  • Novartis Prize for Basic Immunology, 2013
  • Pillar of Immunology, 2005, 2012, 2016
  • Paul Ehrlich and Ludwig Darmstaedter Prize, 2008
  • ASTECH award for Outstanding Leadership in Alberta Science, 1997
  • William B. Coley Award, Cancer Research Institute (USA), 1997
  • Fellow of the Royal Society of Canada, 1995

Education:
  • Ph.D., microbiology, University of British Columbia, Canada (1973)
  • BSc, microbiology, Rhodes University, USA (1969)
  • BS, Chemistry and physiology, University of Natal, South Africa (1968)
return
Proudly powered by Weebly
  • COMPANY
    • ABOUT US
    • EXECUTIVE COMMITTEE
    • SCIENTIFIC ADVISORY BOARD
    • CLINICAL ADVISORY BOARD
    • BOARD OF DIRECTORS
    • PARTNERS
  • SCIENCE
  • PIPELINE
    • OVERVIEW
    • INFLUENZA - OVX836
    • CORONAVIRUS
  • NEWS
    • PRESS RELEASES
    • MEDIA COVERAGE
    • PUBLICATIONS
    • EVENTS
  • CONTACT
    • CAREERS >
      • Analyste Business Development
      • Technicien R&D (H/F) Poste en CDD de 6 mois, basé à Lyon (69)
    • LEGAL MENTIONS